A Study of Multiple Doses of ALXN1210 in Healthy Adult Participants

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study evaluated the safety and tolerability of multiple doses of ALXN1210 (400 and 800 milligrams \[mg\]) following intravenous (IV) administration to healthy participants.
Epistemonikos ID: 720d71fc5846574b3bbf46e5718ae34a6c46e6ae
First added on: May 10, 2024